Swissray

About Swissray

In the world of medical technology, a key playbook has always been to find a better, faster, or cheaper way to see inside the human body. This is the story of Swissray, a company that pioneered the shift from analog to digital in X-ray technology. The company was founded in 1988 with its headquarters in Taiwan, but its research and development remained in Switzerland. The big breakthrough came in 1997. Swissray became the first company to receive FDA clearance to market a direct digital radiography (DR) system. This was a significant moment, eliminating the need for film, cassettes, and chemical processing, and promising high-quality images in seconds at a lower radiation dose. The founder, Ruedi Laupper, was at the forefront of this digital X-ray development. A pivotal event in the company's journey occurred in January 2014 when Swissray acquired the Norland assets from Cooper Surgical. This strategic move broadened Swissray's offerings, adding Norland's respected bone densitometry systems to its portfolio. The acquisition enhanced Swissray's global capabilities and solidified its position in the market for ionizing radiation-based imaging. Today, Swissray's parent company, now known as S&S Healthcare Holding, is publicly held. The company's story is a classic case of seeing a technological shift—the move from analog to digital—and building a lasting enterprise around it.